StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)

Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –

Haemonetics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Haemonetics's price to sales ratio was 4.0× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 1.7× to 4.2×, with a median of 3.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.0×+1.1
2025Dec 31, 20252.8×−0.1
2024Dec 31, 20242.9×−0.6
2023Dec 29, 20233.5×−0.2
2022Dec 30, 20223.7×+0.8
2021Dec 31, 20212.9×−3.8
2020Dec 31, 20206.7×+0.8
2019Dec 31, 20195.9×+0.4
2018Dec 31, 20185.5×+2.1
2017Dec 29, 20173.4×+1.1
2016Dec 30, 20162.3×+0.5
2015Dec 31, 20151.8×−0.2
2014Dec 31, 20142.1×−0.2
2013Dec 31, 20132.3×−0.4
2012Dec 31, 20122.7×+0.5
2011Dec 30, 20112.2×−0.2
2010Dec 31, 20102.4×−0.1
2009Dec 31, 20092.4×–

More Haemonetics figures

See a number that looks wrong?